Drug Type Cell therapy |
Synonyms- |
Target- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization LyGenesis, Inc.Startup |
Active Organization LyGenesis, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
End Stage Liver Disease | Phase 2 | US | LyGenesis, Inc.Startup | 11 Mar 2022 |
liver function failure | Preclinical | US | LyGenesis, Inc.Startup | 09 Aug 2020 |